SL
IDXX icon

Salomon & Ludwin’s Idexx Laboratories IDXX Stock Holding History

Salomon & Ludwin’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1K Sell
23
-28
-55% -$18K ﹤0.01% 1375
2025
Q4 		$34.8K Sell
51
-4
-7% -$2.72K ﹤0.01% 542
2025
Q3 		$34.7K Buy
+55
New +$33.4K ﹤0.01% 505

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Salomon & Ludwin's IDXX Position: Q1 2026 in Review

Salomon & Ludwin reduced its Idexx Laboratories (IDXX) stake by 55% in Q1 2026, selling an estimated $18K and leaving 23 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

Salomon & Ludwin first reported a position in IDXX in Q3 2025 and has held it in 3 quarters since. The position peaked at $34.8K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Salomon & Ludwin held 23 shares of Idexx Laboratories worth $13.1K as of Q1 2026.
  • Salomon & Ludwin sold 28 Idexx Laboratories shares in Q1 2026, an estimated $18K.
  • Idexx Laboratories made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1375 holding.
  • Salomon & Ludwin first reported a position in Idexx Laboratories in Q3 2025 and has held it in 3 quarters since.
  • Salomon & Ludwin's Idexx Laboratories position peaked at $34.8K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.